Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Gordion Bioscience logo — MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA -...

Gordion Bioscience

MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING

Founded 2023 United States Boston, United States 7 employees Biopharma, Biotechnology +3

General Information

Company Name Gordion Bioscience
Founded Year 2023
Location United States Boston, United States
Employees 7
Industries Biopharma, Biotechnology, Health Care +2
Business Model B2B, SaaS, DaaS
Revenue Model Subscription, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Gordion Bioscience. To contact Gordion Bioscience, visit gordion.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Gordion Bioscience compare?

A PDF of Gordion Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Gordion Bioscience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Gordion Bioscience

Gordion Bioscience, founded in 2023, is a promising player in the intersection of biopharma, biotechnology, and machine learning, driving innovation in health care and life sciences.

With a compelling slogan, "MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING," the company emphasizes its mission to leverage cutting-edge technology and data to enhance drug development. Located in the United States, Gordion Bioscience positions itself strategically as a leader in the rapid advancements in precision medicine.

Receiving early investment from Techstars as of 01 October 2023, the startup demonstrates strong potential and credibility within the investment community. This backing not only supports its R&D capabilities but also underlines investor confidence in its innovative approach.

Business keywords: Genomics, Oncology, Cancer Treatment, Tumor Data, Drug Development, Research and Innovation, Precision Medicine, Data-Driven Research, Pharmaceuticals, Bioinformatics, Life Sciences

Services & Products

Target Identification
Portfolio Optimization
Cohort Selection Integration

Target Customers

Pharmaceutical Companies Biotech Firms Oncologists Drug Researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC Undisclosed 1
Techstars
Techstars
01 Oct 2023

Gordion Bioscience Alternatives & Competitors

View All Alternatives
Gordion Bioscience vs
Intelligencia AI
Intelligencia AI United States

Applying machine learning in drug development

Series A
112 employees
AI, Big Data
Gordion Bioscience vs
MNM Bioscience
MNM Bioscience United States

From tumor genomes to AI-driven drug discovery

Seed
2 employees
AI, Biotechnology
Gordion Bioscience vs
iLOF
iLOF United Kingdom

Using AI and Photonics to enable a new era of personalized, precision medicine.

Venture round
40 employees
AI, Biotechnology
View all alternatives

FAQ About Gordion Bioscience

MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING
Gordion Bioscience was founded in 2023.
Gordion Bioscience is headquartered in Boston, United States.
Gordion Bioscience operates in Biopharma, Biotechnology, Health Care, Life Sciences and Machine Learning. Its work centres on Genomics, Oncology, Cancer Treatment and Tumor Data. Its customers include Pharmaceutical Companies, Biotech Firms and Oncologists.
Gordion Bioscience has a B2B, SaaS and DaaS business model. Its revenue comes from Subscription, Service Fee and Licensing.
Gordion Bioscience has approximately 7 employees.
Gordion Bioscience has completed 1 funding round.
Gordion Bioscience offers: Target Identification, Portfolio Optimization, Cohort Selection Integration.
Top alternatives and competitors to Gordion Bioscience include Intelligencia AI, MNM Bioscience, iLOF, Fore Biotherapeutics, iOmx Therapeutics AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gordion Bioscience and Intelligencia AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Gordion Bioscience, https://bouncewatch.com/company/gordion-bioscience, updated 18 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes